IndraLab

Statements

USP34 inhibits cisplatin. 3 / 3
| 3
reach
"Importantly, knockdown of USP34 enhanced cisplatin sensitivity in HepG2 and HepG2/DDP cells."
40051889
reach
"Knockdown of USP34 enhanced cisplatin sensitivity in HepG2 and HepG2/DDP cells."
40051889
reach
"27 The deletion of USP34 inhibited the survival of laryngeal squamous cell carcinoma cells and reduced the drug resistance of cisplatin in these cells."
35588869